GNRHR and ovarian cancer: In SK-OV-3 ovarian cancer cells (expressing GnRHR2 but not GnRHR1), GnRH2 exhibited powerful anti-proliferative effects, unlike triptorelin (19), suggesting that GnRHR2 is mediating these effects.